Loomis, Sayles & Company Portfolio holdings
AUM
$79.8B
1-Year Return
31.99%
This Quarter Return
+6.35%
1 Year Return
+31.99%
3 Year Return
+166.63%
5 Year Return
+219.21%
10 Year Return
+619.03%
AUM
$47.9B
AUM Growth
+$2.28B
(+5%)
Cap. Flow
-$480M
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
34.98%
Holding
994
New
79
Increased
310
Reduced
371
Closed
153
Top Buys
| 1 |
Oracle
ORCL
|
$309M |
| 2 |
Schlumberger
SLB
|
$134M |
| 3 |
Howmet Aerospace
HWM
|
$118M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$87.1M |
| 5 |
Under Armour
UAA
|
$74.3M |
Top Sells
| 1 |
Alibaba
BABA
|
$112M |
| 2 |
ARNC.PRB
Arconic Inc.
ARNC.PRB
|
$104M |
| 3 |
Comcast
CMCSA
|
$61.4M |
| 4 |
AET
Aetna Inc
AET
|
$57.2M |
| 5 |
JPMorgan Chase
JPM
|
$40.8M |
Sector Composition
| 1 | Technology | 18.26% |
| 2 | Consumer Discretionary | 15.2% |
| 3 | Financials | 12.73% |
| 4 | Healthcare | 11.71% |
| 5 | Communication Services | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHPG
576
DELISTED
Shire pic
SHPG
| $54K | ﹤0.01% |
+346
| New | +$54K |
|
|
REXX
577
DELISTED
Rex Energy Corporation
REXX
| $54K | ﹤0.01% |
39,316
| – | – |
|
|
UN
578
DELISTED
Unilever NV New York Registry Shares
UN
| $52K | ﹤0.01% |
+916
| New | +$52K |
|
579
Diageo
DEO
$61.3B
| $51K | ﹤0.01% |
+349
| New | +$51K |
|
580
Leggett & Platt
LEG
$1.35B
| $48K | ﹤0.01% |
1,000
| – | – |
|
581
3M
MMM
$82.7B
| $47K | ﹤0.01% |
240
| – | – |
|
582
Peabody Energy
BTU
$2.33B
| $42K | ﹤0.01% |
1,078
+13
| +1% | +$506 |
|
583
Cars.com
CARS
$835M
| $41K | ﹤0.01% |
1,422
+225
| +19% | +$6.49K |
|
584
Enanta Pharmaceuticals
ENTA
$189M
| $41K | ﹤0.01% |
707
+21
| +3% | +$1.22K |
|
585
Haemonetics
HAE
$2.62B
| $41K | ﹤0.01% |
710
+26
| +4% | +$1.5K |
|
586
Evercore
EVR
$12.3B
| $40K | ﹤0.01% |
445
-14
| -3% | -$1.26K |
|
587
Maximus
MMS
$4.97B
| $40K | ﹤0.01% |
557
+13
| +2% | +$934 |
|
588
Myriad Genetics
MYGN
$615M
| $40K | ﹤0.01% |
1,153
+395
| +52% | +$13.7K |
|
589
United Natural Foods
UNFI
$1.75B
| $40K | ﹤0.01% |
+804
| New | +$40K |
|
590
Moelis & Co
MC
$5.24B
| $39K | ﹤0.01% |
795
-86
| -10% | -$4.22K |
|
591
MGIC Investment
MTG
$6.55B
| $39K | ﹤0.01% |
2,758
-547
| -17% | -$7.74K |
|
592
Rayonier Advanced Materials
RYAM
$397M
| $39K | ﹤0.01% |
1,925
+179
| +10% | +$3.63K |
|
593
Boston Beer
SAM
$2.47B
| $39K | ﹤0.01% |
203
-9
| -4% | -$1.73K |
|
|
MDRX
594
DELISTED
Veradigm Inc. Common Stock
MDRX
| $39K | ﹤0.01% |
2,708
+279
| +11% | +$4.02K |
|
|
AVTA
595
DELISTED
Avantax, Inc. Common Stock
AVTA
| $39K | ﹤0.01% |
1,766
+331
| +23% | +$7.31K |
|
596
Emergent Biosolutions
EBS
$404M
| $38K | ﹤0.01% |
809
-62
| -7% | -$2.91K |
|
597
Encompass Health
EHC
$12.6B
| $38K | ﹤0.01% |
978
+206
| +27% | +$8K |
|
598
Ligand Pharmaceuticals
LGND
$3.25B
| $38K | ﹤0.01% |
446
+113
| +34% | +$9.63K |
|
599
Saic
SAIC
$4.92B
| $38K | ﹤0.01% |
499
-3,345
| -87% | -$255K |
|
600
Wabash National
WNC
$479M
| $38K | ﹤0.01% |
1,770
+127
| +8% | +$2.73K |
|